An Airman assigned to the 489th Aerospace Medical Flight administers the first round of COVID-19 vaccine at Dyess Air Force Base, Texas on Feb. 7.

An Airman assigned to the 489th Aerospace Medical Flight administers the first round of COVID-19 vaccine at Dyess Air Force Base, Texas on Feb. 7. Senior Master Sgt. Ted Daigle/Air Force

The Pandemic’s Deadly Winter Surge Is Rapidly Easing

Cases are down 57 percent from the country’s all-time peak in early January, according to the COVID Tracking Project.

Nationally, all signs point to continued rapid easing of the pandemic’s deadly winter surge. Cases are down 23 percent from the previous week and down 57 percent from the country’s all-time peak in early January when the U.S. recorded 1.7 million new cases in a single week. Hospitalization numbers confirm this rapid decline: There are about 77,000 people hospitalized with COVID-19 in the U.S. as of February 10, down 42 percent from the country’s January 6 record of about 132,000 people. Reported deaths dropped for the second week in a row, with 19,266 deaths reported this week—almost 10 percent fewer than were reported in the previous week. (We have excluded from this count the 1,507 historical deaths Indiana reported with no corresponding dates on February 4; these deaths are included in our API and cumulative death count.) Testing dropped 8 percent this week, the third week of declines for that metric.

Four bar charts showing weekly COVID-19 metrics: tests, cases, average hospitalizations, and deaths. All four metrics declined this week; cases led the way with an almost 23 percent drop

Data users planning to switch to federal data sources when our project ceases data compilation in March will be interested to note that the CDC’s case data match ours almost exactly: The two data sets are 0.018 percent apart on the seven-day average as of February 9.

Two bar charts, each overlaid with a seven-day average, showing daily COVID-19 cases. One is from the COVID Tracking Project; the other, the CDC. As of February 9, the two seven-day averages are within 0.018 percent of each other.

The national case decline is still reflected in a strong downward trajectory in three of the four U.S. census regions—but notably, the Northeast is no longer showing a case drop. We decided to look into that regional signal by investigating regional hospitalizations.

Four area charts, each showing COVID-19 cases per million people over time for a given U.S. region. Cases are falling in three of four regions, but have plateaued slightly in the Northeast.

We often refer to current hospitalizations as a way of helping us understand the severity of COVID-19 outbreaks across the country, but it’s not the only useful hospital metric for this purpose. The current-hospitalizations metric measures the burden on hospitals effectively, but because it is affected by both new COVID-19 admissions and COVID-19 patients leaving the hospital, it’s not as good at revealing the direction of outbreaks. Particularly given that more transmissible variants of SARS-CoV-2 have been identified in much of the country, we’ve also been watching the new hospital-admissions data from the Department of Health and Human Services for early signals of directional change in outbreaks.

A per capita view of the new admissions data suggests that the Midwest, South, and West are all continuing to see new COVID-19 admissions decline, but the Northeast is now showing a small but noticeable increase in new admissions in the seven-day average. The little upward hook in the seven-day average of the Northeast’s hospital admissions chart looks surprisingly similar to the one we saw in regional cases. But where is it coming from?

A state view shows where this admissions data might indicate a worsening situation: Connecticut and New York, especially, are showing notable increases in new admissions. But as we saw during the winter holidays, a confounding factor is in play for some metrics in the Northeast—not a holiday, this time, but the weather.

Four bar charts overlaid with seven-day average showing daily hospital admissions of COVID-19 patients for each major U.S. region. Admissions seem to have ticked up slightly in the Northeast of late

The nor’easter that affected much of the region from January 31 to February 3 appears to be visible in both case and test data as a drop followed by a recovery—and the storm very likely depressed hospital admissions as well, accounting for much of the matching upward tick we’re seeing in that metric in recent days.

Bar charts overlaid with seven-day average showing daily hospital admissions of COVID-19 patients for each state in the Northeast region. While most states are seeing admissions fall, Connecticut, New Jersey, and New York averages have ticked up following the winter storm on February 1

Still, the storm doesn’t explain other worrying indicators: New York currently has the highest per capita number of COVID-19 hospitalizations in the country, and the state’s hospitalizations aren’t falling as rapidly as they have in the recent hot-spot states of Arizona, California, and Georgia. And in a high-population state like New York, high per capita numbers translate into very high absolute counts. The facility-level hospitalization data from HHS provide an overview of COVID-19 hospitalizations across the U.S., including a look at the astonishing scale of hospitalizations in and near New York City.

Map showing hospitals across the U.S. as bubbles. Each bubble size corresponds to the number of COVID-19 patients in that hospital this week. The biggest bubbles are in and around New York City.

Meanwhile, restaurants in New York State will be permitted to reopen indoor dining at 25 percent capacity beginning tomorrow.

We continue to watch every metric closely in the Northeast—and the rest of the country—and we caution data observers to take particular care when identifying short-term trends that may be explicable by non-pandemic factors.


This week’s long-term-care chart excludes data from both Missouri and New York, both of which recently released very large cumulative additions to their data for long-term-care facilities without any corresponding historical time series, resulting in artificial spikes in our national data. The figures from these states are important, and remain in our data set, but when charted, they obscure trends from the rest of the country. Those trends are good: Nursing homes and other long-term-care facilities saw decreases in cases and deaths in our most recent week of data for these facilities, which runs January 28 through February 4.

Three bar charts showing key COVID-19 metrics in long-term-care facilities. Cases and deaths have both declined sharply in recent weeks. Graphs exclude data from Missouri and New York State.

We wrote about Missouri’s release of cumulative historical data on cases and deaths associated with long-term-care facilities in last week’s update, and this week, we have even more confusing data from New York State. Throughout the pandemic, we’ve known that New York’s reported deaths from long-term-care-facility outbreaks were an undercount, because the state attributed deaths to long-term-care facilities only if patients actually died in the long-term-care facility. Any resident who contracted COVID-19 in an outbreak in a nursing home or assisted-living facility in New York and then died after being taken to a hospital, for example, was counted as a COVID-19 death in New York State, but not as a long-term-care-facility death.

On January 28, after New York Attorney General Letitia James called attention to New York’s undercount of deaths in nursing homes, state Health Commissioner Howard Zucker issued a statement that attributed to New York State nursing homes an additional 3,829 deaths that occurred as far back as March 1, 2020. In the two weeks since this statement, New York has added a total of 5,620 deaths associated with nursing homes and long-term-care facilities to its dashboard, nearly doubling the state’s cumulative count of deaths associated with these facilities.

New York has not provided any dates for these deaths, so we’re unable to backfill them into the correct weeks. Based on average reporting from the state in January, it is likely that up to about 600 of these deaths took place recently. This suggests that the state’s audit has to date revealed approximately 5,000 deaths associated with outbreaks in nursing homes and assisted-living facilities that the state had previously declined to attribute to those outbreaks.

Meanwhile, a peer-reviewed study of more than 13,000 U.S. nursing homes published this week in JAMA Network Open suggests that nursing homes with the highest proportions of nonwhite residents experienced COVID-19 death counts that were more than three times higher than those of facilities with the highest proportions of white residents.


The testing decline we’re now seeing is almost certainly due to a combination of reduced demand as well as reduced availability or accessibility of testing. Demand for testing may have dropped because fewer people are sick or have been exposed to infected individuals, but also perhaps because testing isn’t being promoted as heavily.

The resolution of holiday reporting backlogs also almost certainly produced an artificial spike in the number of tests reported in early January—which means the decline we’re seeing now looks particularly dramatic when measured against that postholiday spike.

Bar chart showing daily U.S. COVID-19 reported tests, overlaid with seven-day average line. Tests have declined in recent weeks from their peak in early January.

Even if we adjust for holiday effects and estimate that we’re really testing only 1 million fewer people each week than we did a month ago, that’s unequivocally the wrong direction for a country that needs to understand the movements of the virus during a slow vaccine rollout and the spread of multiple new variants.

According to public-health experts, we’re also still not doing enough testing, —and we weren’t doing enough even at the January testing peak. Back in October, the Harvard Global Health Institute and NPR released testing targets that set a national target of about 2 million PCR tests a day. If we discount holiday effects, the United States finally hit that target in the week ending January 20, when states reported about 14 million tests—though the number immediately began dropping. But the HGHI test targets were based on October 1 case counts, and even after weeks of declines, we’re seeing more than twice as many new cases a day now as in early October. Vaccinations are only one component of the effort to get the pandemic under control and prevent another devastating surge. We need to be testing at our full capacity—and increasing that capacity—to keep eyes on the pandemic as we move into spring.

Both testing and hospitalization data are crucially important COVID-19 metrics, helping us understand how the pandemic is changing and how to interpret other data we’re collecting. The race and ethnicity data for these metrics remain deeply inadequate in both state and federal data sources. Nearly a year into the U.S. pandemic, only 23 states report or have reported any data about the race and ethnicity of people hospitalized with COVID-19, and only nine states share data about the race and ethnicity of people who receive COVID-19 tests. As Marcella Nunez-Smith, the chair of the Biden-Harris COVID-19 Health Equity Task Force, said at a Kaiser Family Foundation briefing in December 2020, “There is violence in data invisibility. We cannot address what we cannot see. We are making a choice every time we allow poor-quality data to hinder our ability to intervene on racial and ethnic inequities.”

Two maps, one showing the states reporting race / ethnicity data for COVID-19 hospitalizations, the other showing the states reporting race / ethnicity data for COVID-19 tests. 23 states have reported some hospitalization data, and 9 report testing data.

Although media and policy attention is increasingly focused on the lack of demographic data for vaccinations—data on race and ethnicity are missing for about half of all first doses administered in the first month of the U.S. vaccine rollout, according to a CDC report—demographic data for other COVID-19 metrics remain essential for identifying inequities in either impact or response. Without good, public demographic data on hospitalizations and tests, there can be no accountability for efforts to identify and address inequities. States and the federal government should work together to ensure that hospitals and testing providers are collecting sufficient demographic data, and that these data are rapidly and publicly shared.

This article was originally published in The Atlantic. Sign up for their newsletter

X
This website uses cookies to enhance user experience and to analyze performance and traffic on our website. We also share information about your use of our site with our social media, advertising and analytics partners. Learn More / Do Not Sell My Personal Information
Accept Cookies
X
Cookie Preferences Cookie List

Do Not Sell My Personal Information

When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about the First and Third Party Cookies used please follow this link.

Allow All Cookies

Manage Consent Preferences

Strictly Necessary Cookies - Always Active

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data, Targeting & Social Media Cookies

Under the California Consumer Privacy Act, you have the right to opt-out of the sale of your personal information to third parties. These cookies collect information for analytics and to personalize your experience with targeted ads. You may exercise your right to opt out of the sale of personal information by using this toggle switch. If you opt out we will not be able to offer you personalised ads and will not hand over your personal information to any third parties. Additionally, you may contact our legal department for further clarification about your rights as a California consumer by using this Exercise My Rights link

If you have enabled privacy controls on your browser (such as a plugin), we have to take that as a valid request to opt-out. Therefore we would not be able to track your activity through the web. This may affect our ability to personalize ads according to your preferences.

Targeting cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

Social media cookies are set by a range of social media services that we have added to the site to enable you to share our content with your friends and networks. They are capable of tracking your browser across other sites and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do not allow these cookies you may not be able to use or see these sharing tools.

If you want to opt out of all of our lead reports and lists, please submit a privacy request at our Do Not Sell page.

Save Settings
Cookie Preferences Cookie List

Cookie List

A cookie is a small piece of data (text file) that a website – when visited by a user – asks your browser to store on your device in order to remember information about you, such as your language preference or login information. Those cookies are set by us and called first-party cookies. We also use third-party cookies – which are cookies from a domain different than the domain of the website you are visiting – for our advertising and marketing efforts. More specifically, we use cookies and other tracking technologies for the following purposes:

Strictly Necessary Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Functional Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Performance Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Social Media Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Targeting Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.